Flexibility, capacity and expanded menu plus the ability to run laboratory developed tests.
Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. With the Panther Fusion® Module you can consolidate testing, increase walkaway time and enhance flexibility.
-
Up to 32 assay reagent kits on board, which allow assay consolidation on a single platform.
-
Ready-to-use reagent cartridges reduce manual preparation and operator errors.
-
Sample throughput up to 500 tests in 8 hours increases test volume in a shift without increasing staff.
-
Minimal hardware/software changes allow additional testing without extensive retraining or SOP updates.
-
Open Access™ functionality provides full automation to run laboratory developed tests with IVDs.
-
Time-to-first result at 2.4 hours allows patient results to be released sooner and improves turnaround time.
- Add on additional IVD menu without disrupting existing workflow.
-
Run up to 5 PCR reactions from a single (360μL) patient extraction, reducing extraction time and costs.
-
60-day onboard stability of reagents and fluids minimizes reagent waste for better cost management.
-
Utilize existing Panther system LIS connection for Panther Fusion assays, reducing LIS costs.
-
In-lab upgrade increases test volumes, throughput and menu without replacing equipment or infrastructure.
Consolidate Your Assay Menu
The Aptima® and Panther Fusion® Assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.
Assays that run on the Panther Fusion System
Women's & Sexual Health
CT/NG
Chlamydia trachomatis
Neisseria gonorrhoeae
Mycoplasma genitalium 
Trichomonas vaginalis
Bacterial vaginosis
Candida vaginitis/Trichomonas vaginalis
HSV 1 & 2
HPV EXPANDED PRIMARY CLAIM
HPV 16 18/45 EXPANDED PRIMARY CLAIM
GBS
M. gen Resistance* IN DEV NG Resistance* IN DEV
Acute Care, Virals & Transplant
HIV-1 Quant Dx
HCV Quant Dx
HBV Quant
CMV Quant
Flu A/B/RSV
Paraflu
AdV/hMPV/RV
SARS-CoV-2
SARS-CoV-2/Flu A/B/RSV
GI Bacterial
GI Extended Bacterial GI Viral* IN DEV GI Parasite* IN DEV C. difficile* IN DEV
* In Development and not for sale
Related Products
Flexibility, capacity and expanded menu plus the ability to run laboratory developed tests
Add on the power to run real-time PCR, TMA and RT-TMA assays on a single, fully automated platform. With the Panther Fusion® Module you can consolidate testing, increase walkaway time and enhance flexibility.
-
Up to 32 assay reagent kits on board, which allow assay consolidation on a single platform
-
Ready-to-use reagent cartridges reduce manual preparation and operator errors
-
Sample throughput up to 500 tests in 8 hours increases test volume in a shift without increasing staff
-
Minimal hardware/software changes allow additional testing without extensive retraining or SOP updates
-
Open Access™ functionality provides full automation to run laboratory developed tests with IVDs
-
Time-to-first result at 2.4 hours allows patient results to be released sooner and improves turnaround time
- Add on additional IVD menu without disrupting existing workflow
-
Run up to 5 PCR reactions from a single (360μL) patient extraction, reducing extraction time and costs
-
60-day onboard stability of reagents and fluids minimizes reagent waste for better cost management
-
Utilize existing Panther® system LIS connection for Panther Fusion® assays, reducing LIS costs
-
In-lab upgrade increases test volumes, throughput and menu without replacing equipment or infrastructure
Consolidate your assay menu
The Aptima® and Panther Fusion® Assays help guide patient care and enable early detection. With a menu and pipeline of world-class assays you can consolidate your molecular testing today and meet your lab’s growing needs tomorrow.
Assay that run on the Panther Fusion System
Women’s & Sexual Health
CT/NG Chlamydia trachomatis Neisseria gonorrhoeae Mycoplasma genitalium Trichomonas vaginalis Bacterial vaginosis Candida vaginitis/Trichomonas vaginalis HSV 1 & 2 HPV EXPANDED PRIMARY CLAIM HPV 16 18/45 EXPANDED PRIMARY CLAIM GBS M. gen Resistance* IN DEV
Acute Care, Virals & Transplant
HIV-1 Quant HCV Quant HBV Quant CMV Quant
EBV Quant
BKV Quant SARS-CoV-2 SARS-CoV-2/Flu A/B/RSV Flu A/B/RSV Paraflu AdV/hMPV/RV
Bordetella
MRSA GI Bacterial GI Extended Bacterial GI Viral* IN DEV GI Parasite* IN DEV C. difficile* IN DEV
* In Development and not for sale
Related Products
